Boehringer Ingelheim Venture Fund
4 rounds tracked since 7 July 2025.
- Rounds
- 4
- Led
- 3
- Capital in these rounds
- $80.4M
Sectors
Countries
Rounds
- SRTD BiotechLeadDevelops precision mRNA therapies targeting diseased cells $35.3MSeed · 3 Nov
- TECregenLeadBiologics to regenerate the thymus and restore T-cell immunity $12.5MSeed · 8 Jan
- STRM.BIOLeadNon-viral gene delivery platform for in vivo cell engineering $8MSeed · 7 Jan
- EvlaBioBiotech developing an antibody for left ventricular hypertrophy in chronic kidney disease. $24.6MSeed · 7 Jul
No round matches these filters.